Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-089346
Filing Date
2022-08-11
Accepted
2022-08-11 16:07:46
Documents
5
Effectiveness Date
2022-08-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2222890d1_s8.htm S-8 71639
2 EXHIBIT 5.1 tm2222890d1_ex5-1.htm EX-5.1 9455
3 EXHIBIT 23.2 tm2222890d1_ex23-2.htm EX-23.2 2146
4 EXHIBIT 107 tm2222890d1_ex107.htm EX-FILING FEES 16137
5 GRAPHIC tm2222890d1_ex5-1img001.jpg GRAPHIC 4416
  Complete submission text file 0001104659-22-089346.txt   106756
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266780 | Film No.: 221155736
SIC: 2834 Pharmaceutical Preparations